Medicine Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
Preventive Medicine and Public Health Teaching and Research Unit, Rey Juan Carlos University, Alcorcón, Madrid, Spain.
Eur J Intern Med. 2019 Jan;59:53-59. doi: 10.1016/j.ejim.2018.08.011. Epub 2018 Aug 22.
To compare trends in incidence, clinical characteristics and outcomes of heart failure (HF) hospitalizations among patients with or without type 2 diabetes (T2DM) in Spain (2001-2015).
We used national hospital discharge data to select hospital admissions for HF as primary diagnosis. Incidence, comorbidities, diagnostic and therapeutic procedures, and in hospital mortality (IHM) were analyzed.
We identified a total of 1,501,811 admissions for HF (36.87% with T2DM). Incidences were higher among those with T2DM than those without diabetes. The adjusted incidence of HF among T2DM patients was 4.93 higher than for non-diabetic subjects (IRR 4.93;95%CI 4.91-4.95). Jointpoint analysis showed that sex-age-adjusted admissions in T2DM patients with HF increased by 7.12% per year from 2001 to 2007 and stabilized afterwards. For non-diabetic patients a constant increase overtime of around 1% was found. Patients with T2DM were significantly younger than patients without diabetes (77.22 vs. 79.36 years) and had more coexisting medical conditions according to the Charlson Comorbidity Index (mean CCI 1.99 ± 0.88 vs. 1.90 ± 0.86). For the total time period, crude IHM was lower for T2DM patients than for non-diabetic people (8.35% vs, 10.57%; p < 0.05) and the association remained significant after multivariable adjustment ((OR, 0.84; 95%CI 0.83-0.86).). Female sex, older age and multiple comorbidities were significant risk factors for IHM.
T2DM increases the risk of admission for HF by five-fold. Our study demonstrates an increase in hospitalization for HF in diabetic patients from 2001 to 2007 and stabilization afterwards. T2DM was associated with a lower IHM after hospitalization for HF.
比较 2001 年至 2015 年间西班牙有和无 2 型糖尿病(T2DM)的心力衰竭(HF)住院患者的发病率、临床特征和结局趋势。
我们使用国家医院出院数据选择 HF 作为主要诊断的住院治疗。分析了发病率、合并症、诊断和治疗程序以及住院死亡率(IHM)。
我们共确定了 1501811 例 HF 住院治疗(36.87%有 T2DM)。有 T2DM 的患者发病率高于无糖尿病的患者。T2DM 患者 HF 的校正发病率比非糖尿病患者高 4.93 倍(IRR 4.93;95%CI 4.91-4.95)。联合点分析显示,2001 年至 2007 年,HF 合并 T2DM 患者的性别年龄调整入院人数每年增加 7.12%,之后稳定下来。对于非糖尿病患者,发现随着时间的推移,住院人数呈持续增加,约为 1%。与无糖尿病患者相比,T2DM 患者明显更年轻(77.22 岁比 79.36 岁),根据 Charlson 合并症指数(平均 CCI 1.99±0.88 比 1.90±0.86)有更多的并存疾病。在整个时间段内,T2DM 患者的 IHM 低于非糖尿病患者(8.35%比 10.57%;p<0.05),多变量调整后这种关联仍然显著((OR,0.84;95%CI 0.83-0.86))。女性、年龄较大和多种合并症是 IHM 的显著危险因素。
T2DM 使 HF 入院风险增加五倍。我们的研究表明,2001 年至 2007 年间糖尿病患者 HF 住院人数增加,之后稳定下来。HF 住院后,T2DM 与较低的 IHM 相关。